Abstract
Ototoxicity is a rare and disabling complication in bisphosphonate therapy. Here we describe two patients who encountered further hearing loss during oral etidronate treatment for osteoporosis.
Author supplied keywords
Cite
CITATION STYLE
APA
Çomlekçi, A. (1998). Further hearing loss during osteoporosis treatment with etidronate. Postgraduate Medical Journal, 74(872), 363–364. https://doi.org/10.1136/pgmj.74.872.363
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free